Centre hospitalier d'Argenteuil, 95107 Argenteuil, France.
Centre hospitalier et universitaire de Rennes, 35033 Rennes, France.
Anaesth Crit Care Pain Med. 2017 Jun;36(3):151-155. doi: 10.1016/j.accpm.2016.11.006. Epub 2017 Jan 16.
Perioperative goal-directed therapy (PGDT) has been demonstrated to improve postoperative outcomes and reduce the length of hospital stays. The objective of our analysis was to evaluate the cost of complications, derived from French hospital payments, and calculate the potential cost savings and length of hospital stay reductions.
The billing of 2388 patients who underwent scheduled high-risk surgery (i.e. major abdominal, gynaecologic, urological, vascular, and orthopaedic interventions) over three years was retrospectively collected from three French hospitals (one public-teaching, one public, and one private hospital). A relationship between mortality, length of hospital stays, cost/patient, and severity scores, based mainly on postoperative complications but also on preoperative clinical status, were analysed. Statistical analysis was performed using Student's t-tests or Wilcoxon tests.
Our analyses determined that a severity score of 3 or 4 was associated with complications in 90% of cases and this represented 36% of patients who, compared with those with a score of 1 or 2, were associated with significantly increased costs (€ 8205±3335 to € 22,081±16,090; P<0.001, delta of € 13,876) and a prolonged length of hospital stay (mean of 10 to 27 days; P<0.001, delta of 17 days). According to estimates for complications avoided by PGDT, there was a projected reduction in average healthcare costs of between € 854 and € 1458 per patient and a reduction in total hospital bed days from 1755 to 4423 over three years. Based on French National data (47,000 high risk surgeries per year), the potential financial savings ranged from € 40M to € 68M, not including the costs of PGDT and its implementation.
Our analysis demonstrates that patients with complications are significantly more expensive to care for than those without complications. In our model, it was projected that implementing PGDT during high-risk surgery may significantly reduce healthcare costs and the length of hospital stays in France while probably improving patient access to care and reducing waiting times for procedures.
围手术期目标导向治疗(PGDT)已被证明可以改善术后结果并缩短住院时间。我们分析的目的是评估并发症的成本,这些成本来自法国医院的支付,并计算潜在的成本节约和住院时间缩短。
从法国的三家医院(一家公立教学医院、一家公立医院和一家私立医院)回顾性收集了 2388 名接受高风险手术(即主要腹部、妇科、泌尿科、血管和骨科手术)的患者的计费数据,为期三年。主要基于术后并发症,但也基于术前临床状况,分析了死亡率、住院时间、每位患者的费用/成本和严重程度评分之间的关系。使用学生 t 检验或 Wilcoxon 检验进行统计分析。
我们的分析确定,严重程度评分为 3 或 4 与 90%的并发症相关,这代表了 36%的患者,与评分为 1 或 2 的患者相比,这些患者的费用显著增加(€8205±3335 至 €22081±16090;P<0.001,差值为 €13876),住院时间延长(平均 10 至 27 天;P<0.001,差值为 17 天)。根据避免 PGDT 并发症的估计,预计每位患者的平均医疗保健费用将降低 854 至 1458 欧元,三年内总住院天数将从 1755 天减少到 4423 天。根据法国国家数据(每年 47000 例高风险手术),潜在的财务节省范围在 4000 万至 6800 万欧元之间,不包括 PGDT 及其实施成本。
我们的分析表明,有并发症的患者的护理费用明显高于没有并发症的患者。在我们的模型中,预计在高风险手术中实施 PGDT 可能会显著降低法国的医疗保健成本和住院时间,同时可能改善患者获得护理的机会并减少手术等待时间。